Novo Nordisk grant to Pia Rantakari and Klaus Elenius
The Novo Nordisk Foundation awarded 2024 grants to five researchers from the University of Turku, totaling approximately €2,204,294.
Among the grant recipients were:
Docent, InFLAMES and Turku Bioscience group leader Pia Rantakari. Her research titled Unveiling the Role of Pituitary Gland Macrophages in Polycystic Ovarian Syndrome: Towards Novel Therapeutics got DKK 2.997.685 (approx. 401 988 €) funding.
Professor, BioCity Turku Director, Turku Bioscience group leader Klaus Elenius. His research titled Overcoming Cancer drUg Resistance by targeting ERBB3 (CURE) got DKK 5.981.741 (approx. 802 149 €) funding.
Warm congratulations!
Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026